User profiles for D. Galasko

Douglas Galasko

UCSD
Verified email at ucsd.edu
Cited by 103167

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

…, DJ Burn, D Costa, T Del Ser, B Dubois, D Galasko… - Neurology, 2005 - AAN Enterprises
The dementia with Lewy bodies (DLB) Consortium has revised criteria for the clinical and
pathologic diagnosis of DLB incorporating new information about the core clinical features and …

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report of the consortium on DLB international workshop

IG McKeith, D Galasko, K Kosaka, EK Perry… - Neurology, 1996 - AAN Enterprises
Recent neuropathologic autopsy studies found that 15 to 25% of elderly demented patients
have Lewy bodies (LB) in their brainstem and cortex, and in hospital series this may …

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium

…, TJ Ferman, D Ffytche, H Fujishiro, D Galasko… - Neurology, 2017 - AAN Enterprises
… e28 Patients at risk of falling may benefit from safety assessments, as well as bone mineral
density screening, and assessment of vitamin D status, to manage risk of traumatic fractures. …

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

…, MN Rossor, JD Warren, NC Fox, D Galasko… - Brain, 2011 - academic.oup.com
Based on the recent literature and collective experience, an international consortium developed
revised guidelines for the diagnosis of behavioural variant frontotemporal dementia. The …

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

…, GB Frisoni, NC Fox, D Galasko… - The Lancet …, 2014 - thelancet.com
In the past 8 years, both the International Working Group (IWG) and the US National Institute
on Aging–Alzheimer's Association have contributed criteria for the diagnosis of Alzheimer's …

[HTML][HTML] Vitamin E and donepezil for the treatment of mild cognitive impairment

…, D Bennett, R Doody, S Ferris, D Galasko… - … England Journal of …, 2005 - Mass Medical Soc
Background Mild cognitive impairment is a transitional state between the cognitive changes
of normal aging and early Alzheimer's disease. Methods In a double-blind study, we …

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

…, MR Farlow, S Ferris, MP Frosch, DR Galasko… - Nature …, 2011 - nature.com
The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association
study of late-onset Alzheimer disease using a three-stage design consisting of a discovery …

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

…, J Cummings, A Delacourte, D Galasko… - The Lancet …, 2007 - thelancet.com
The NINCDS–ADRDA and the DSM-IV-TR criteria for Alzheimer's disease (AD) are the
prevailing diagnostic standards in research; however, they have now fallen behind the …

The Parkinson progression marker initiative (PPMI)

…, D Berg, K Gauss, D Galasko, D Fontaine… - Progress in …, 2011 - Elsevier
The Parkinson Progression Marker Initiative (PPMI) is a comprehensive observational,
international, multi-center study designed to identify PD progression biomarkers both to improve …

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

L Hansen, D Salmon, D Galasko, E Masliah… - Neurology, 1990 - AAN Enterprises
Thirty-six clinically diagnosed and pathologically confirmed Alzheimer's disease (AD)
patients included 13 with cortical and subcortical Lewy bodies (LBs). The patients with LBs …